Nephrocare Health Services Limited IPO
Nephrocare Health Services Limited IPO
Nephrocare Health Services Limited IPO
₹ 14720 / 32 Shares Shares
Minimum Investment
Nephrocare Health Services Limited IPO
Issues Price
₹438-460 per equity share
Nephrocare Health Services Limited IPO
Open Date
10 Dec 2025
Close Date
12 Dec 2025
Lot Size
16
Min. Investment
₹ 14720
Issue Price
₹438-460
Listing Date
17 Dec 2025
Issues Size
1,89,35,819 shares(aggregating up to ₹871.05 crore)
Face Value
₹2 Per Equity Share
Total Shares Offered
32 Shares
Offered To Public
32 Shares
Nephrocare Health Services Limited IPO
Nephrocare Health Services Ltd, incorporated in the year 2010, is an end-to-end dialysis care provider through its wide network of clinics across India and select international markets. It offers services such as diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of March 31, 2025, Nephrocare operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 269 cities in 21 States and four Union Territories. Approximately 76.73% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions. In Fiscal 2025, Nephrocare treated 29,281 patients and performed more than 2.88 million dialysis treatments, amounting to approximately 10% of the country's total dialysis patient base. The number of dialysis machines operated by the company increased to 5,068 as of March 2025 from 4,714 in Fiscal 2024 and 3,662 in Fiscal 2023. Nephrocare has formulated strategic alliances with leading hospital chains like Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers. As of March 2025, the workforce consisted of 3,230 employees, including both medical and administrative staff working across its clinics and corporate office.
Founded In
2010
Managing Director
Vikram Vuppala
Parent Organization
Nephrocare Health Services Limited IPO
Application for Nephrocare Health Services Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹438-460 | ₹14,720 |
| Retail(max) | ₹438-460 | ₹1,91,360 |
| SHNI(min) | ₹438-460 | ₹2,06,080 |
| SHNI(max) | ₹438-460 | ₹9,86,240 |
| BHNI(min) | ₹438-460 | ₹10,00,960 |
Apply for all eligible candidates, Nephrocare Health Services Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare helped me invest in Indian markets with zero stress. Their NRI Corner is truly designed for people living abroad.
As someone new to investing, KSquare’s SIP guidance has been incredibly helpful. Their platform is user-friendly, and the support team answered all my questions patiently.
KSquare’s mutual fund platform is exactly what I needed. It’s intuitive, offers diverse funds, and gives great insights. I’ve seen real growth since I started.
KSquare’s SIP plans align perfectly with my monthly savings goals. I appreciate how effortless the process is. It's really helped me become financially disciplined.
KSquare’s recommendations are on point. Their mutual fund picks are backed by solid research, and I’ve seen consistent returns over the past year.
I was impressed by how seamless KSquare’s NRI services are. They handled my documentation with care and helped me invest without unnecessary hassle.
I had doubts about NPS before. KSquare explained every detail, making my decision easy. Their support and transparency are unmatched.
KSquare made investing so simple! Their SIP options fit my monthly budget and help me build wealth consistently without worry. I highly recommend it to anyone starting their financial journey.
KSquare helped me borrow against my mutual funds with minimal paperwork. I’m impressed by their speed and support.
NPS through KSquare was a seamless experience. Their regular updates and advice on risk levels helped a lot.
FAQ's
Frequenlty Asked Question
How does KSquare select and list New Fund Offerings?
KSquare features only SEBI-registered, vetted NFOs and provides research insights to help investors make informed choices.
Are NFOs safe for first-time investors?
NFOs can be suitable for beginners, but they carry risks. KSquare helps assess fund strategies before you commit.
Can I invest in SIPs from abroad with KSquare?
Yes, NRIs can set up SIPs through their NRE/NRO accounts. KSquare automates the process for convenience.
Can I prepay the loan without penalties?
Most lenders allow prepayment without extra charges. KSquare ensures these terms are clearly shared before you proceed.
Are mutual funds suitable for short-term goals?
Debt and liquid funds are ideal for short-term goals, while equity funds are better for long-term wealth creation.
How does KSquare help in retirement planning?
KSquare builds long-term SIP strategies to create a secure retirement corpus based on future lifestyle, needs, and inflation.
What types of mutual funds are available on KSquare?
KSquare offers equity, debt, hybrid, ELSS, and index funds to suit different financial goals and risk profiles.
What is the National Pension System (NPS)?
NPS is a government-backed retirement savings scheme that lets you invest during your working life and withdraw upon retirement.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.